Crystal structure and mechanistic implications of N2-(2-carboxyethyl)arginine synthase, the first enzyme in the clavulanic acid biosynthesis pathway.
The initial step in the biosynthesis of the clinically important beta-lactamase inhibitor clavulanic acid involves condensation of two primary metabolites, D-glyceraldehyde 3-phosphate and L-arginine, to give N2-(2-carboxyethyl)arginine, a beta-amino acid. This unusual N-C bond forming reaction is c...
Main Authors: | , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2004
|
_version_ | 1797087918837202944 |
---|---|
author | Caines, M Elkins, J Hewitson, K Schofield, C |
author_facet | Caines, M Elkins, J Hewitson, K Schofield, C |
author_sort | Caines, M |
collection | OXFORD |
description | The initial step in the biosynthesis of the clinically important beta-lactamase inhibitor clavulanic acid involves condensation of two primary metabolites, D-glyceraldehyde 3-phosphate and L-arginine, to give N2-(2-carboxyethyl)arginine, a beta-amino acid. This unusual N-C bond forming reaction is catalyzed by the thiamin diphosphate (ThP2)-dependent enzyme N2-(2-carboxyethyl)arginine synthase. Here we report the crystal structure of N2-(2-carboxyethyl)arginine synthase, complexed with ThP2 and Mg2+, to 2.35-A resolution. The structure was solved in two space groups, P2(1)2(1)2(1) and P2(1)2(1)2. In both, the enzyme is observed in a tetrameric form, composed of a dimer of two more tightly associated dimers, consistent with both mass spectrometric and gel filtration chromatography studies. Both ThP2 and Mg2+ cofactors are present at the active site, with ThP2 in a "V" conformation as in related enzymes. A sulfate anion is observed in the active site of the enzyme in a location proposed as a binding site for the phosphate group of the d-glyceraldehyde 3-phosphate substrate. The mechanistic implications of the active site arrangement are discussed, including the potential role of the aminopyrimidine ring of the ThP2. The structure will form a basis for future mechanistic and structural studies, as well as engineering aimed at production of alternative beta-amino acids. |
first_indexed | 2024-03-07T02:42:25Z |
format | Journal article |
id | oxford-uuid:aae7ac78-1891-4b32-b36d-544ec6e05b88 |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-07T02:42:25Z |
publishDate | 2004 |
record_format | dspace |
spelling | oxford-uuid:aae7ac78-1891-4b32-b36d-544ec6e05b882022-03-27T03:18:19ZCrystal structure and mechanistic implications of N2-(2-carboxyethyl)arginine synthase, the first enzyme in the clavulanic acid biosynthesis pathway.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:aae7ac78-1891-4b32-b36d-544ec6e05b88EnglishSymplectic Elements at Oxford2004Caines, MElkins, JHewitson, KSchofield, CThe initial step in the biosynthesis of the clinically important beta-lactamase inhibitor clavulanic acid involves condensation of two primary metabolites, D-glyceraldehyde 3-phosphate and L-arginine, to give N2-(2-carboxyethyl)arginine, a beta-amino acid. This unusual N-C bond forming reaction is catalyzed by the thiamin diphosphate (ThP2)-dependent enzyme N2-(2-carboxyethyl)arginine synthase. Here we report the crystal structure of N2-(2-carboxyethyl)arginine synthase, complexed with ThP2 and Mg2+, to 2.35-A resolution. The structure was solved in two space groups, P2(1)2(1)2(1) and P2(1)2(1)2. In both, the enzyme is observed in a tetrameric form, composed of a dimer of two more tightly associated dimers, consistent with both mass spectrometric and gel filtration chromatography studies. Both ThP2 and Mg2+ cofactors are present at the active site, with ThP2 in a "V" conformation as in related enzymes. A sulfate anion is observed in the active site of the enzyme in a location proposed as a binding site for the phosphate group of the d-glyceraldehyde 3-phosphate substrate. The mechanistic implications of the active site arrangement are discussed, including the potential role of the aminopyrimidine ring of the ThP2. The structure will form a basis for future mechanistic and structural studies, as well as engineering aimed at production of alternative beta-amino acids. |
spellingShingle | Caines, M Elkins, J Hewitson, K Schofield, C Crystal structure and mechanistic implications of N2-(2-carboxyethyl)arginine synthase, the first enzyme in the clavulanic acid biosynthesis pathway. |
title | Crystal structure and mechanistic implications of N2-(2-carboxyethyl)arginine synthase, the first enzyme in the clavulanic acid biosynthesis pathway. |
title_full | Crystal structure and mechanistic implications of N2-(2-carboxyethyl)arginine synthase, the first enzyme in the clavulanic acid biosynthesis pathway. |
title_fullStr | Crystal structure and mechanistic implications of N2-(2-carboxyethyl)arginine synthase, the first enzyme in the clavulanic acid biosynthesis pathway. |
title_full_unstemmed | Crystal structure and mechanistic implications of N2-(2-carboxyethyl)arginine synthase, the first enzyme in the clavulanic acid biosynthesis pathway. |
title_short | Crystal structure and mechanistic implications of N2-(2-carboxyethyl)arginine synthase, the first enzyme in the clavulanic acid biosynthesis pathway. |
title_sort | crystal structure and mechanistic implications of n2 2 carboxyethyl arginine synthase the first enzyme in the clavulanic acid biosynthesis pathway |
work_keys_str_mv | AT cainesm crystalstructureandmechanisticimplicationsofn22carboxyethylargininesynthasethefirstenzymeintheclavulanicacidbiosynthesispathway AT elkinsj crystalstructureandmechanisticimplicationsofn22carboxyethylargininesynthasethefirstenzymeintheclavulanicacidbiosynthesispathway AT hewitsonk crystalstructureandmechanisticimplicationsofn22carboxyethylargininesynthasethefirstenzymeintheclavulanicacidbiosynthesispathway AT schofieldc crystalstructureandmechanisticimplicationsofn22carboxyethylargininesynthasethefirstenzymeintheclavulanicacidbiosynthesispathway |